View in EDS HTML Full Text PDF Full Text

Combination therapy with anamorelin and a myostatin inhibitor is advantageous for cancer cachexia in a mouse model.

Saved in:
Bibliographic Details
Title: Combination therapy with anamorelin and a myostatin inhibitor is advantageous for cancer cachexia in a mouse model.
Authors: Hanada K; Laboratory of Stem Cell Regulation, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan., Fukasawa K; Laboratory of Stem Cell Regulation, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan., Hinata H; Laboratory of Stem Cell Regulation, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan., Imai S; Laboratory of Stem Cell Regulation, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan., Takayama K; Department of Medicinal Chemistry, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.; Department of Environmental Biochemistry, Kyoto Pharmaceutical University, Kyoto, Japan., Hirai H; Laboratory of Stem Cell Regulation, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan., Ohfusa R; Department of Medicinal Chemistry, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan., Hayashi Y; Department of Medicinal Chemistry, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan., Itoh F; Laboratory of Stem Cell Regulation, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.
Source: Cancer science [Cancer Sci] 2022 Oct; Vol. 113 (10), pp. 3547-3557. Date of Electronic Publication: 2022 Aug 06.
Publication Type: Journal Article
Journal Info: Publisher: Wiley Publishing on behalf of the Japanese Cancer Association Country of Publication: England NLM ID: 101168776 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1349-7006 (Electronic) Linking ISSN: 13479032 NLM ISO Abbreviation: Cancer Sci Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35849084
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Combination therapy with anamorelin and a myostatin inhibitor is advantageous for cancer cachexia in a mouse model.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hanada+K%22">Hanada K</searchLink>; Laboratory of Stem Cell Regulation, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Fukasawa+K%22">Fukasawa K</searchLink>; Laboratory of Stem Cell Regulation, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Hinata+H%22">Hinata H</searchLink>; Laboratory of Stem Cell Regulation, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Imai+S%22">Imai S</searchLink>; Laboratory of Stem Cell Regulation, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Takayama+K%22">Takayama K</searchLink>; Department of Medicinal Chemistry, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.; Department of Environmental Biochemistry, Kyoto Pharmaceutical University, Kyoto, Japan.<br /><searchLink fieldCode="AU" term="%22Hirai+H%22">Hirai H</searchLink>; Laboratory of Stem Cell Regulation, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Ohfusa+R%22">Ohfusa R</searchLink>; Department of Medicinal Chemistry, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Hayashi+Y%22">Hayashi Y</searchLink>; Department of Medicinal Chemistry, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Itoh+F%22">Itoh F</searchLink>; Laboratory of Stem Cell Regulation, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101168776%22">Cancer science</searchLink> [Cancer Sci] 2022 Oct; Vol. 113 (10), pp. 3547-3557. <i>Date of Electronic Publication: </i>2022 Aug 06.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley+Publishing+on+behalf+of+the+Japanese+Cancer+Association%22">Wiley Publishing on behalf of the Japanese Cancer Association </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101168776 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1349-7006 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213479032%22">13479032 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Sci <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35849084
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/cas.15491
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3547
    Titles:
      – TitleFull: Combination therapy with anamorelin and a myostatin inhibitor is advantageous for cancer cachexia in a mouse model.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hanada K
      – PersonEntity:
          Name:
            NameFull: Fukasawa K
      – PersonEntity:
          Name:
            NameFull: Hinata H
      – PersonEntity:
          Name:
            NameFull: Imai S
      – PersonEntity:
          Name:
            NameFull: Takayama K
      – PersonEntity:
          Name:
            NameFull: Hirai H
      – PersonEntity:
          Name:
            NameFull: Ohfusa R
      – PersonEntity:
          Name:
            NameFull: Hayashi Y
      – PersonEntity:
          Name:
            NameFull: Itoh F
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2022 Oct
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1349-7006
          Numbering:
            – Type: volume
              Value: 113
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: Cancer science
              Type: main
ResultId 1